Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Albendazole inhibits colon cancer progression and therapy resistance by targeting ubiquitin ligase RNF20

Published:2024-01-26 Issue:6 Volume:130 Page:1046-1058
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Fatima Iram,Ahmad Rizwan,Barman Susmita,Gowrikumar Saiprasad,Pravoverov Kristina,Primeaux Mark,Fisher Kurt W.,Singh Amar B.^ORCID,Dhawan Punita^ORCID

Funder

U.S. Department of Health & Human Services | NIH | NIH Office of the Director

Department of Veterans Affairs | Office of Academic Affiliations, Department of Veterans Affairs

U.S. Department of Health & Human Services | NIH | Center for Information Technology

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41416-023-02570-x.pdf

Reference95 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

2. Fatima I, Uppada JP, Chhonker YS, Gowrikumar S, Barman S, Roy S, et al. Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis. Biomed Pharmacother. 2023;159:114255.

3. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72:409–36.

4. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

5. Ciardiello F, Ciardiello D, Martini G, Napolitano S, Tabernero J, Cervantes A. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J Clin. 2022;72:372–401.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3